Clinical Trials in Ohio

Showing 7301-7320 of 15,929 trials

Vitala 12 Hour Wear Test With Convex Products

NCT01138709

The primary objective of this phase II clinical trial is to assess the safety of the Vitala™ device during 12 hours of daily wear with convex products.

End Colostomy

ConvaTec Inc.27 participantsStarted Feb 2010

Tucson, Arizona, United States • Jacksonville, Florida, United States • Kansas City, Missouri, United States +2 more locations

COMPLETEDEARLY Phase 132 miles

The Response to Atropine Drops (RAD) Study

NCT05199597

The purpose of this study is to examine the comfort of giving low concentration atropine eye drops.

Myopia

Ohio State University30 participantsStarted May 2022

Columbus, Ohio, United States

TERMINATEDPhase 332 miles

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

NCT00858364

This is a study in patients with chemotherapy induced anemia receiving multi-cycle chemotherapy for the treatment of stage IV non-small cell lung cancer (NSCLC). The primary objective of the study is to demonstrate that overall survival (OS) is not worse in participants on darbepoetin alfa treated to a hemoglobin ceiling of 12.0 g/dL compared to participants treated with placebo.

Non-Small Cell Lung CancerAnemiaCancer+1 more

Amgen2,549 participantsStarted Jul 2009

Anniston, Alabama, United States • Birmingham, Alabama, United States • Anchorage, Alaska, United States +563 more locations

Vitala 12 Hour Wear Test With Convex Products

The Response to Atropine Drops (RAD) Study

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Find Trials by Condition in Ohio

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

A Clinical Trial of PRAX-114 in Participants With Essential Tremor

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Negative Pressure Wound Therapy to Reduce Surgical Site Infection

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

The International Diabetes Closed Loop (iDCL) Trial: Protocol 4

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory